Lenz Therapeutics Stock Filter Stocks by Fundamentals
| LENZ Stock | 37.30 1.05 2.90% |
LENZ Therapeutics fundamentals help investors to digest information that contributes to LENZ Therapeutics' financial success or failures. It also enables traders to predict the movement of LENZ Stock. The fundamental analysis module provides a way to measure LENZ Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LENZ Therapeutics stock.
LENZ | Shares Owned by Institutions |
Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
LENZ Fundamentals
| Return On Equity | -1.58 | ||||
| Return On Asset | -0.77 | ||||
| Current Valuation | 406.07 M | ||||
| Shares Outstanding | 27.47 M | ||||
| Shares Owned By Insiders | 5.40 % | ||||
| Shares Owned By Institutions | 86.06 % | ||||
| Number Of Shares Shorted | 2.18 M | ||||
| Price To Book | 3.11 X | ||||
| EBITDA | (122.24 M) | ||||
| Net Income | (124.65 M) | ||||
| Total Debt | 362 K | ||||
| Book Value Per Share | 7.46 X | ||||
| Cash Flow From Operations | (90.01 M) | ||||
| Short Ratio | 17.72 X | ||||
| Earnings Per Share | (2.74) X | ||||
| Target Price | 33.8 | ||||
| Market Capitalization | 600.49 M | ||||
| Total Asset | 188.46 M | ||||
| Retained Earnings | (367.05 M) | ||||
| Annual Yield | 0.89 % | ||||
| Net Asset | 188.46 M |
About LENZ Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LENZ Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LENZ Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LENZ Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.